학술논문
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
Document Type
Article
Author
Kroegel, Claus; Caruso, Cristiano; Baglivo, Ilaria; Colantuono, Stefania; Jackson, David; Skowasch, Dirk; Di Marco, Fabiano; Couturaud, Francis; Käßner, Frank; Cwiek, Iwona; Teber, Markus; Knetsch, Kornelia; Preuß, Jasmin; Devouassoux, Gilles; Milger-Kneidinger, Katrin; Heaney, Liam; Jerrentrup, Lukas; Humbert, Marc; Jandl, Margret; Timmermann, Hartmut; Probst, Beatrice; D'Amato, Maria; Hoffmann, Martin; Bonniaud, Philippe; Beltramo, Guillaume; Girodet, Pierre-Olivier; Berger, Patrick; Nasser, Shuaib; Fry, Stéphanie; Korn, Stephanie; Aries, Sven Philip; Koehler, Thomas; Harrison, Timothy; Jackson, David J ; Heaney, Liam G; Kent, Brian D; Shavit, Anat; Hiljemark, Lina; Olinger, Lynda; Cohen, David; Menzies-Gow, Andrew
Source
In The Lancet 20-26 January 2024 403(10423):271-281
Subject
Language
ISSN
0140-6736